Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CYP2D6 Polymorphism on Carvedilol PK/PD
NCT02286934Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carvedilol in hypertension (HTN) and heart failure (HF), sponsored by Seoul National University Hospital. Primary endpoints: Area Under the Plasma Concentration-Time Curve and Maximum Plasma Concentration. Started Sep 2014; status: completed.
02
Drugs
carvedilol
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT02286934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286934.